20 results
8-K
EX-99.2
RVNC
Revance Therapeutics Inc
9 May 24
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
4:08pm
.
“DAXXIFY provides a significant opportunity for Revance and marks the culmination of our decades-long mission to bring true innovation
PRE 14A
79vpbvxr9h7
12 Mar 21
Preliminary proxy
4:13pm
424B3
pmq7a
24 Jun 20
Prospectus supplement
5:18pm
S-4/A
z8wsgx2m6 re
23 Jun 20
Registration of securities issued in business combination transactions (amended)
6:09am
S-4
66aefbr48bosq
9 Jun 20
Registration of securities issued in business combination transactions
9:48pm
425
3hviol kj12
19 May 20
Business combination disclosure
8:18am
8-K
EX-99.1
w5nldg8a
19 May 20
Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices
8:15am
8-K
EX-99.1
7bxy3v1p8
4 Dec 18
Entry into a Material Definitive Agreement
8:14am
- Prev
- 1
- Next